SH2D1A and X-linked lymphoproliferative disease: Defects in CD4+ T cells may contribute to impaired anti-EBV immunity in XLP because analysis of the CD4+ T cell compartment from XLP carriers revealed a predominant response by SAP+ CD4+ T cells to EBV lysate in vitro (Figure S4).